Translational Neuroendocrinology
51 – 100 of 126
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Psychiatric and metabolic disturbances in experimental models of Huntington’s disease
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Effects of Deletion of Mutant Huntingtin in Steroidogenic Factor 1 Neurons on the Psychiatric and Metabolic Phenotype in the BACHD Mouse Model of Huntington Disease.
(
- Contribution to journal › Article
-
Mark
Twisting mice move the dystonia field forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1α
(
- Contribution to journal › Article
- 2013
-
Mark
Maintenance of Basal Levels of Autophagy in Huntington's Disease Mouse Models Displaying Metabolic Dysfunction.
(
- Contribution to journal › Article
-
Mark
Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Ethical aspects of undergoing a predictive genetic testing for Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntingtons disease
(
- Contribution to journal › Article
- 2012
-
Mark
No diagnostic value of plasma clusterin in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Progranulin Bridges Energy Homeostasis and Fronto-Temporal Dementia
(
- Contribution to journal › Letter
-
Mark
Characterization of a rat model of Huntington's disease based on targeted expression of mutant huntingtin in the forebrain using adeno-associated viral vectors.
(
- Contribution to journal › Article
-
Mark
Expression of Mutant Huntingtin in Leptin Receptor-Expressing Neurons Does Not Control the Metabolic and Psychiatric Phenotype of the BACHD Mouse.
(
- Contribution to journal › Article
-
Mark
For Better or for Worse: Lifeworld, System and Family Caregiving for a Chronic Genetic Disease.
(
- Contribution to journal › Article
- 2011
-
Mark
Eating and Hypothalamus Changes in Behavioral-Variant Frontotemporal Dementia
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits.
(
- Contribution to journal › Article
-
Mark
Increased numbers of orexin/hypocretin neurons in a genetic rat depression model.
(
- Contribution to journal › Article
- 2010
-
Mark
NEUROPEPTIDE AND HYPOTHALAMUS CHANGES IN FRONTOTEMPORAL DEMENTIA AND HUNTINGTON'S DISEASE
2010) 10th Biennial Meeting of the Asia-Pacific Society of Neurochemistry In Journal of Neurochemistry 115(Suppl. 1). p.1-1(
- Contribution to journal › Published meeting abstract
-
Mark
A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons
(
- Contribution to journal › Article
-
Mark
Hypothalamic and Neuroendocrine Changes in Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
(
- Contribution to journal › Article
-
Mark
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.
(
- Contribution to journal › Article
-
Mark
Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses.
(
- Contribution to journal › Article
- 2009
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model
(
- Contribution to journal › Article
-
Mark
Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
(
- Contribution to journal › Article
-
Mark
Huntington's Disease - New Perspectives Based on Neuroendocrine Changes in Rodent Models.
(
- Contribution to journal › Article
-
Mark
Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model.
(
- Contribution to journal › Article
-
Mark
Beyond the brain: widespread pathology in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.
(
- Contribution to journal › Article
-
Mark
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity.
(
- Contribution to journal › Article
-
Mark
Malignt neuroleptikasyndrom--sällsynt diagnos med hög dödlighet.
(
- Contribution to journal › Scientific review
-
Mark
Reduced CSF CART in dementia with Lewy bodies.
(
- Contribution to journal › Article
-
Mark
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin.
(
- Contribution to journal › Article
-
Mark
Harnessing immune alterations in neurodegenerative diseases.
(
- Contribution to journal › Article
- 2008
-
Mark
Cocaine and amphetamine regulated transcript (CART) in suicide attempters.
(
- Contribution to journal › Article
-
Mark
Hippocampal cytogenesis is increased in FSL strain, a genetic rat model of depression. Escitalopram reduces increased cell number
2008) XXVI CINP Congress In International Journal of Neuropsychopharmacology 11(Supplement S1). p.124-125(
- Contribution to journal › Published meeting abstract
-
Mark
Increased metabolism in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Transthyretin in cerebrospinal fluid from suicide attempters.
(
- Contribution to journal › Article
-
Mark
Increased thirst and drinking in Huntington's disease and the R6/2 mouse
(
- Contribution to journal › Article
-
Mark
Role of neuroticism and neurochemical changes in suicidal behaviour
2008) XXVI CINP Congress In International Journal of Neuropsychopharmacology 11(Supplement S1). p.132-132(
- Contribution to journal › Published meeting abstract
-
Mark
Hippocampal cytogenesis is increased in a genetic rat model of depression. Escitalopram reduces increased cell number
2008) 21st Congress of the European-College-of-Neuropsychopharmacology In European Neuropsychopharmacology 18(S4). p.323-323(
- Contribution to journal › Published meeting abstract
-
Mark
Sex differences in a transgenic rat model of Huntington's disease: decreased 17 beta-estradiol levels correlate with reduced numbers of DARPP32(+) neurons in males
(
- Contribution to journal › Article
-
Mark
Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus
(
- Contribution to journal › Article
-
Mark
Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model.
(
- Contribution to journal › Article
-
Mark
Islet beta-cell area and hormone expression are unaltered in Huntington's disease.
(
- Contribution to journal › Article
- 2007
-
Mark
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
(
- Contribution to journal › Article
-
Mark
Testicular degeneration in Huntington disease
(
- Contribution to journal › Article
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article
-
Mark
Orexin and psychiatric symptoms in suicide attempters.
(
- Contribution to journal › Article
-
Mark
Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine
(
- Contribution to journal › Article